Showing 951 results

Filters Content type: News, Editors' picks, About HIV Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

HIV treatment

Viral Load Reductions Persist With Less Efavirenz for HIV

Editor's pick
Medscape (requires free registration)
7 November 2014
Diabetes

Inflammatory markers associated with development of diabetes in people taking HIV therapy

News
20 October 2014
New & experimental hepatitis C treatment

IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

Editor's pick
HIVandHepatitis.com
16 October 2014
Mental & emotional health problems

IDWeek 2014: Efavirenz Not Linked to Suicide in Analysis of Insurance Records

Editor's pick
HIVandHepatitis.com
16 October 2014
Side effects

Effective treatments available for HIV patients not eligible for efavirenz regimens

Editor's pick
Science Daily
7 October 2014
Starting treatment

Why I Refused, Then Later Embraced, HIV Treatment

Editor's pick
TheBody.com
1 October 2014
Kidney problems

Guidelines Advise Against Tenofovir for HIV Patients With Kidney Disease

Editor's pick
The Body Pro
22 September 2014
Side effects

Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

Editor's pick
NATAP
16 September 2014
Side effects

New Tenofovir Alafenamide Combo Pill Has Less Effect on Kidneys and Bones

Editor's pick
HIVandhepatitis.com
9 September 2014
Starting treatment

Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment

News
23 July 2014
Weight gain & lipodystrophy

Drug that reduces abdominal fat in HIV patients also may reduce fat in liver

Editor's pick
Eurekalert Medicine & Health
19 July 2014
Mental & emotional health problems

Common HIV Drug May Boost Suicide Risk

Editor's pick
Web MD
2 July 2014
Diabetes

Protease inhibitor therapy increases underlying genetic risk of diabetes for women with HIV

News
1 July 2014
Side effects

Lowering toxicity of new HIV drugs predicted to improve life expectancy

Editor's pick
EurekAlert
26 June 2014
TB treatment

In HIV/TB coinfection, raltegravir may be an alternative to efavirenz

Editor's pick
Medscape
2 June 2014
Side effects

Risk score can help predict which people living with HIV have highest risk of kidney disease during tenofovir treatment

News
31 March 2014
Side effects

Heart attack link to abacavir persists in D:A:D study

News
14 March 2014
HIV treatment

Raltegravir has the edge over two protease inhibitors in three-drug comparison study

News
7 March 2014
Kidney problems

ART use not linked to advanced kidney disease in 35,000 with HIV

Editor's pick
International AIDS Society
12 February 2014
Bone & joint problems

HIV increases fracture risk, say Danes

News
4 February 2014
History of HIV & AIDS

What ‘Dallas Buyers Club’ got wrong about the AIDS crisis

Editor's pick
Washington Post
11 December 2013
Weight gain & lipodystrophy

Unusual and rare complication described in San Francisco

Editor's pick
CATIE
9 December 2013
Side effects

Differing Effects of Low- and High-Fat Meals on New Raltegravir Formulation

Editor's pick
NATAP
30 October 2013
Starting treatment

Dual therapy with Kaletra and 3TC works well regardless of viral load

News
20 October 2013